Alex Nichols & Brian Fiske, Mythic Therapeutics co-founders

Rid­ing an ADC hot streak, a new biotech bets a megaround that a bet­ter ver­sion of those ther­a­pies is­n't a myth

While most biotech star­tups be­gin with a light bulb mo­ment or in-li­censed tech­nol­o­gy, Myth­ic Ther­a­peu­tics’ roots trace back to a din­ing room ta­ble and an emp­ty note­book.

Alex Nichols and Bri­an Fiske shared an of­fice at Flag­ship be­fore they left a few years ago to cre­ate some­thing in­de­pen­dent. They want­ed to iden­ti­fy a mean­ing­ful prob­lem for pa­tients and solve it. Sev­er­al note­books lat­er, they land­ed on a mis­sion: cre­at­ing a safer, more ef­fec­tive an­ti­body-drug con­ju­gate.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.